How to find and enroll in a cancer immunotherapy clinical trial: Dr. Ezra Cohen shares what to expect and addresses common misconceptions. #CRIsummit #immunotherapy #ClinicalTrials
[ Ссылка ]

Dr. Ezra Cohen (UC San Diego Moores Cancer Center) explores cancer immunotherapy clinical trials at the 2020 CRI Virtual Immunotherapy Patient Summit. Clinical trials are essential to bringing promising new therapies to patients, often for the first time or in new combinations with other treatments. So, what is a clinical trial? What are common misconceptions about clinical trials? How can you access cancer immunotherapy clinical trials? How has the current COVID-19 pandemic affected patient participation in clinical trials? [ Ссылка ]

In this video, Dr. Ezra Cohen busts these clinical trial myths:
- Myth: "I might only get placebo or a sugar pill instead of treatment."
- Myth: "Clinical trials are only for people who have run out of treatment options."
- Myth: "I need to travel to a large hospital or cancer center to participate in a clinical trial."
- Myth: "My health insurance doesn't cover the cost of care in a clinical trial."
- Myth: "Signing a consent form locks me into staying in a clinical trial."
- Myth: "I will be made to feel like a guinea pig experiment."
- Myth: "Clinical trials aren't safe."

Dr. Ezra Cohen answers viewer questions about clinical trials:
- "Does a physician always have to make a referral for you to join a clinical trial?"
- "What is the length of time you are generally on a clinical trial? Can you decide to stay on a trial longer if the treatment is working?"
- "Can you decide to stay on a trial longer if the treatment is right working?"
- "Can immunotherapy with other types of cancer treatment like chemotherapy and radiation?"
- “Will tumor genome testing hurt my chance of getting into an immunotherapy clinical trial?”
- "At what point in my treatment should I start looking for a clinical trial?"
- "How is COVID-19 impacting clinical research? Is it still safe to enroll in a clinical trial?"
- "What is the role of immunotherapy for patients with rare cancers?"
- "If I were to enroll in a clinical trial, would I lose my current oncologist?"

Dr. Ezra Cohen is chief of the Division of Hematology‐Oncology, and co‐director of the San Diego Center for Precision Immunotherapy. A physician‐scientist, Dr. Cohen led an independently funded laboratory interested in mechanisms of action of novel therapeutics. He has made major contributions to targeted and immunotherapy. His research has received peer‐reviewed funding in the study of epidermal growth factor receptor inhibitors, cell therapy, and immunotherapy in head and neck cancer. He has made major contributions to the understanding of critical signaling pathways, integration of novel agents into standard of care, and definition of mechanisms to overcome resistance to drug therapy. He has also recently co‐developed a personalized neoantigen vaccine using unique cancer mutations to boost an anti‐tumor immune response.

The 2020 CRI Virtual Immunotherapy Patient Summit is part of the Cancer Research Institute's Answer to Cancer Patient Education Program. Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. [ Ссылка ]

Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.

свернуть